Covered recipient · General Payments record
STEVEN ALPHONSO KING
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$1,916.67
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $371.38 | 21 |
| Education | $54.54 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $201.56 | 13 |
| E.R. Squibb & Sons, L.L.C. | $87.27 | 3 |
| Axsome Therapeutics, Inc. | $44.49 | 1 |
| ITI, Inc. | $36.31 | 2 |
| Vanda Pharmaceuticals Inc. | $29.12 | 2 |
| Lundbeck LLC | $27.17 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.56 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078584 | CMS |
| ABBVIE INC. | $19.65 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078586 | CMS |
| ABBVIE INC. | $11.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078588 | CMS |
| ABBVIE INC. | $7.64 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078590 | CMS |
| ABBVIE INC. | $22.62 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078592 | CMS |
| ABBVIE INC. | $9.18 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078594 | CMS |
| ABBVIE INC. | $10.29 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078596 | CMS |
| ABBVIE INC. | $23.84 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078598 | CMS |
| ABBVIE INC. | $2.58 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078600 | CMS |
| ABBVIE INC. | $12.76 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078602 | CMS |
| ABBVIE INC. | $14.46 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078604 | CMS |
| ABBVIE INC. | $32.30 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078606 | CMS |
| ABBVIE INC. | $16.35 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078608 | CMS |
| Axsome Therapeutics, Inc. | $44.49 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148322790 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 10/03/2024 | Education | Undisputed | 01/23/2026 | 1101202242 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 10/16/2024 | Education | Undisputed | 01/23/2026 | 1101202246 | CMS |
| E.R. Squibb & Sons, L.L.C. | $32.73 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101202256 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.85 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143257603 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17.46 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143257606 | CMS |
| Lundbeck LLC | $13.78 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145934184 | CMS |
| Lundbeck LLC | $13.39 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145934186 | CMS |
| Vanda Pharmaceuticals Inc. | $13.25 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133908853 | CMS |
| Vanda Pharmaceuticals Inc. | $15.87 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133908855 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.